Close
ACHEMA MIDDLE EAST 2026

Takara Bio and Boston IVF Fertility Center Announce Partnership to Enable the Derivation of Clinical-grade hES cell lines for Cell Therapy Applications

Takara Bio Europe AB (TBEAB) is proud to officially announce a partnership with the Boston IVF Fertility Center (Boston IVF) headquartered in Waltham, Massachusetts,...

Medrio and PHASTAR Unite to Offer Data Visualization for Clinical Trials

Medrio, Inc. a leading provider of decentralized and eClinical technology to pharmaceutical, biotech, medical device, diagnostics, and animal health markets and PHASTAR, a global...

Reliance obtains DCGI approval to conduct Phase I Covid-19 vaccine trial

Reliance Life Sciences has obtained approval from the Drugs Controller General of India (DCGI) to carry out a Phase I clinical trial of its...

I-Mab Reports Positive Interim Analysis from Phase 2/3 Study of its GM-CSF Antibody Plonmarlimab to Treat Patients with Severe COVID-19

I-Mab, a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, announced positive interim data from its U.S. phase 2/3...

Valneva Initiates Further Phase 3 Clinical Trial for its COVID-19 Vaccine Candidate

Valneva SE, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, announced...

AzurRx expands trial of drug for Covid-19-linked GI infections to Ukraine

AzurRx BioPharma has expanded the ongoing Phase II RESERVOIR clinical trial of FW-1022 for the treatment of Covid-19-related gastrointestinal (GI) infections in Ukraine. The company...

INOVIO Doses First Participant in Phase 2 Trial for its DNA Vaccine Against Middle East Respiratory Syndrome (MERS), a Coronavirus Disease

INOVIO, a biotechnology company bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases, today...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...